Biosimilar matches rituximab in large follicular lymphoma trialSeptember 12, 2017Aggressive Lymphomas
Copanlisib makes inroads against relapsed/refractory follicular lymphomaJuly 11, 2017Indolent Lymphoma
Pembrolizumab + rituximab boost response rates in relapsed follicular lymphomaJune 26, 2017Indolent Lymphoma
Bendamustine plus rituximab may have edge for treating indolent NHL, MCLJune 22, 2017Indolent Lymphoma
Lenalidomide-rituximab induces high CR rate in untreated follicular lymphomaJune 21, 2017Indolent Lymphoma
GALEN safe and effective in relapsed and refractory follicular lymphomaJune 20, 2017Indolent Lymphoma
